STERIS plc at Morgan Stanley Global Healthcare Conference Transcript

Sep 15, 2026 / 05:05PM GMT
Release Date Price: R$52.14
Tejas Savant
Morgan Stanley & Co Ltd - Analyst

All right. We're going to get started here. First of all, welcome to Dan from STERIS. Thanks again for joining us. We're excited to unpack parts of the story.

Before we get into it, there is a disclaimer on the Morgan Stanley website, so I suggest everybody go check that out. Dan, I just learned that it was Dan's 29th anniversary year at STERIS, but importantly also five years as CEO, so congratulations on that.

Questions & Answers

Tejas Savant
Morgan Stanley & Co Ltd - Analyst

Maybe to start us off, you can reflect a bit about what you learned in the last five years about STERIS and that as CEO that you didn't appreciate when you first took the role on, and maybe what you think investors still underappreciate about this story.

Daniel Carestio
STERIS plc - President, Chief Executive Officer, Director

Yeah, thank you, and thank you for having me. I think the one thing that I would really point to is how resilient and how durable the demand

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot